MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Country |
 USA |
IPO year |
2019 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
29 M |
Market Cap[1] |
$ 553 M |
EBITDA (LTM) |
$ -20.7 M |
P/E (LTM) |
-19.8 |
P/S (LTM) |
2.02 |
EPS (LTM) |
-1.25 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
$ 1.29 | -20.63 % | $ 1.72 M | Nasdaq Capital Market | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Fulgent Genetics
FLGT
|
$ 15.93 | -1.61 % | $ 482 M | Nasdaq Global Market | USA |
 |
Agilent Technologies
A
|
$ 112.11 | -1.0 % | $ 34.1 B | NYSE,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 140.65 | -1.81 % | $ 22.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Interpace Biosciences
IDXG
|
$ 1.8 | - | $ 7.96 M | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 19.81 | -3.32 % | $ 1.06 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Lantheus Holdings
LNTH
|
$ 93.98 | -2.78 % | $ 6.34 B | Nasdaq Global Select Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Medpace Holdings
MEDP
|
$ 419.51 | 0.08 % | $ 12.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 046.9 | 0.48 % | $ 21.6 B | NYSE,SPB |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Myriad Genetics
MYGN
|
$ 3.61 | -0.28 % | $ 334 M | Nasdaq Global Select Market,SPB | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 8.28 | -1.02 % | $ 1.06 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 155.13 | -2.51 % | $ 7.69 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
National Research Corporation
NRC
|
$ 18.58 | -1.85 % | $ 416 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 187.34 | -4.86 % | $ 18.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 25.34 | -0.65 % | $ 24 B | NYSE |  Niderland |
 |
Guardant Health
GH
|
$ 93.18 | -5.56 % | $ 11.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 5.73 | -1.63 % | $ 239 M | NYSE American | USA |
 |
Personalis
PSNL
|
$ 6.5 | -3.2 % | $ 580 M | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 117.79 | 0.6 % | $ 9.72 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
$ 52.99 | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Biomerica
BMRA
|
$ 2.36 | -2.07 % | $ 5.42 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 252.4 | -0.64 % | $ 21 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 441.45 | -1.49 % | $ 166 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.57 | -1.7 % | $ 205 M | Nasdaq Global Select Market | Irlanda |
 |
Celcuity
CELC
|
$ 134.95 | 0.17 % | $ 6.31 B | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Twist Bioscience Corporation
TWST
|
$ 48.89 | -7.67 % | $ 2.92 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 8.28 | -1.78 % | $ 1.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Waters Corporation
WAT
|
$ 332.25 | -0.29 % | $ 19.8 B | NYSE,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 186.87 | -0.57 % | $ 20.7 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.